Health
Despite Drug Industry Claims, Higher List Prices Do Mean Higher Out-of-Pocket Costs for Many Patients – Gizmodo Australia
New research suggests that as the list price of brand name drugs rise, so do out-of-pocket medical costs for these drugs — at least for some patients. This is counter…
New research suggests that as the list price of brand name drugs rise, so do out-of-pocket medical costs for these drugs at least for some patients. This is counter to a common industry claim that patients arent affected by list price increases. The study found a link between list prices rising and out-of-pocket increases among people with private insurance plans that mandated deductibles and coinsurance. These patients also didnt seem to benefit from rebates passed down by drug makers to insurance…
-
Noosa News8 hours agoHow Lily Steele-Park took her rapist to court and won
-
General22 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business13 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General23 hours agoQantas ‘contacted by potential cybercriminal’ after attack on data of up to 6 million customers